Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.54 USD | +0.49% | -0.95% | +12.63% |
05-15 | Ovintiv Insider Sold Shares Worth $600,000, According to a Recent SEC Filing | MT |
05-15 | Ovintiv Maintained at Buy at UBS Following First-Quarter Results; Price Target Raised to US$70.00 | MT |
Evolution of the average Target Price on Ovintiv Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Ovintiv Inc.
UBS | |
Mizuho Securities | |
RBC Capital Markets | |
Tudor Pickering Holt & Co. | |
National Bank Financial | |
Morgan Stanley | |
Goldman Sachs | |
Citigroup | |
Wells Fargo Securities |
EPS Revisions
- Stock Market
- Equities
- OVV Stock
- Consensus Ovintiv Inc.